Augmedix, Inc. Quarterly Operating Income (Loss) in USD from Q4 2018 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Augmedix, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2018 to Q2 2024.
- Augmedix, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$8.73M, a 76.8% decline year-over-year.
- Augmedix, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$23.9M, a 14.1% decline year-over-year.
- Augmedix, Inc. annual Operating Income (Loss) for 2023 was -$18.8M, a 16.1% increase from 2022.
- Augmedix, Inc. annual Operating Income (Loss) for 2022 was -$22.4M, a 27.5% decline from 2021.
- Augmedix, Inc. annual Operating Income (Loss) for 2021 was -$17.6M, a 28.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)